{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:17:23Z","timestamp":1793330243358,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cardfail.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:01:17Z","timestamp":1681725677000},"page":"787-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society"],"prefix":"10.1016","volume":"29","author":[{"given":"HIROYUKI","family":"Tsutsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NANCY M.","family":"ALBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW J.S.","family":"COATS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEFAN D.","family":"ANKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTONI","family":"BAYES-GENIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAVED","family":"BUTLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OVIDIU","family":"CHIONCEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTOPHER R.","family":"DEFILIPPI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARK H.","family":"DRAZNER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. MICHAEL","family":"FELKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GERASIMOS","family":"FILIPPATOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MONA","family":"FIUZAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMOMI","family":"IDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"JAMES L.","family":"JANUZZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHIRO","family":"KINUGAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHIRO","family":"KUWAHARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUYA","family":"MATSUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT J.","family":"MENTZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARCO","family":"METRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMBARISH","family":"PANDEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIUSEPPE","family":"ROSANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIHIKO","family":"SAITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUSHI","family":"SAKATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NAOKI","family":"SATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETAR M.","family":"SEFEROVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"TEERLINK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUHIRO","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHIHIRO","family":"YOSHIMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.02.009_bib0001","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0002","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0003","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0004","first-page":"99","article-title":"Electron microscopy of the atrium of the heart. I. Guinea pig","volume":"14","author":"Kisch","year":"1956","journal-title":"Exp Med Surg"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"De Bold","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0006","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-291X(84)91077-5","article-title":"Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)","volume":"118","author":"Kangawa","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0008","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/338078a0","article-title":"A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor","volume":"338","author":"Chinkers","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0009","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1672777","article-title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)","volume":"252","author":"Koller","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0010","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIRCULATIONAHA.107.732990","article-title":"Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart","volume":"117","author":"Tokudome","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0011","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCHEARTFAILURE.113.000885","article-title":"Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11897-016-0292-x","article-title":"Neprilysin and natriuretic peptide regulation in heart failure","volume":"13","author":"Bayes-Genis","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0013","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0014","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","author":"Mangiafico","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2459\/JCM.0000000000000329","article-title":"Natriuretic peptide-guided management in heart failure","volume":"17","author":"Chioncel","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0016","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2004.06.015","article-title":"Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath","volume":"44","author":"Maisel","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0017","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","article-title":"Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure","volume":"258","author":"Rubio-Gracia","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0019","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: Findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0020","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ejhf.1492","article-title":"Acute heart failure congestion and perfusion status: impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"21","author":"Chioncel","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0021","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCHEARTFAILURE.111.962290","article-title":"Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims","volume":"4","author":"Kociol","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0022","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijcard.2016.07.117","article-title":"Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction","volume":"221","author":"Omar","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0023","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1751-7133.2012.00304.x","article-title":"Post-acute care: the role of natriuretic peptides","volume":"18","author":"Maisel","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/heartjnl-2013-303632","article-title":"A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European collaboration on Acute decompensated Heart Failure: ELAN-HF Score","volume":"100","author":"Salah","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0025","first-page":"437","article-title":"Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure","volume":"9","author":"Mi\u00f1ana","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0026","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.320","article-title":"Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?","volume":"17","author":"Stienen","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0027","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ejhf.2493","article-title":"Cardiac remodelling part 1: from cells and tissues to circulating biomarkers of the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Gonz\u00e1lez","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0028","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.117.029882","volume":"137","author":"Stienen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0029","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjcard.2015.05.046","article-title":"Predictors of six-month mortality in BNP-matched acute heart failure patients","volume":"116","author":"Lourenco","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0030","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N- terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0031","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.hlc.2019.02.004","article-title":"BNP-response to acute heart failure treatment identifies high-risk population","volume":"29","author":"Patel","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0032","doi-asserted-by":"crossref","first-page":"G19","DOI":"10.1093\/eurheartj\/suw045","article-title":"The bumpy road to drug development for acute heart failure","volume":"18","author":"Hamo","year":"2016","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0033","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","article-title":"Effect of ularitide on cardiovascular mortality in acute heart failure","volume":"376","author":"Packer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0034","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1801291","article-title":"Effects of serelaxin in patients with acute heart failure","volume":"381","author":"Metra","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ejhf.2493","article-title":"Cardiac remodelling part 1: from cells and tissues to circulating biomarkers of the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Gonz\u00e1lez","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0036","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jchf.2020.10.008","article-title":"Unexpectedly low natriuretic peptide levels in patients with heart failure","volume":"9","author":"Bachmann","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0037","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2020.11.066","article-title":"Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction","volume":"327","author":"Sakane","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0040","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0041","doi-asserted-by":"crossref","first-page":"k1450","DOI":"10.1136\/bmj.k1450","article-title":"Diagnostic accuracy of point-of-care natriuretic peptide testing for chronic heart failure in ambulatory care: systematic review and meta-analysis","volume":"361","author":"Taylor","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0042","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/eurheartj\/ehq163","article-title":"Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care","volume":"31","author":"Hildebrandt","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0043","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0044","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jacc.2012.12.044","article-title":"B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction","volume":"61","author":"van Veldhuisen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00392-008-0728-8","article-title":"Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction","volume":"98","author":"Letsas","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0046","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0047","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with sacubitril\/valsartan: The PARADIGM-HF trial","volume":"73","author":"Myhre","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0048","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/eurheartj\/ehab082","article-title":"The struggle towards a Universal Definition of heart failure - How to proceed?","volume":"42","author":"Cleland","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0049","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0050","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1253\/circj.CJ-21-0431","article-title":"JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0051","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jchf.2019.12.009","article-title":"Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: Insights from COMMANDER HF","volume":"8","author":"Cunningham","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0052","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jacc.2021.07.046","article-title":"Prognostic importance of NT-proBNP and effect of empagliflozin in the EMPEROR-reduced trial","volume":"78","author":"Januzzi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0053","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jchf.2020.03.002","article-title":"Effects of sacubitril\/valsartan on N-terminal pro-B-type natriuretic peptide in heart failure with preserved ejection fraction","volume":"8","author":"Cunningham","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0054","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jacbts.2016.03.001","article-title":"Detection and management of geographic disparities in the TOPCAT trial: Lessons learned and derivative eecommendations","volume":"1","author":"Bristow","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jchf.2020.01.007","article-title":"Should enrichment with natriuretic peptide levels be mandatory in global clinical trials?","volume":"8","author":"Voors","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0056","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cpt.2222","article-title":"NT-proBNP qualifies as a surrogate for clinical end points in heart failure","volume":"110","author":"Schmitt","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0057","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jchf.2018.02.007","article-title":"Natriuretic peptides as biomarkers of treatment response in clinical trials of heart failure","volume":"6","author":"Vaduganathan","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0058","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.1411","article-title":"Relation between therapy-induced changes in natriuretic peptide levels and long-term therapeutic effects on mortality in patients with heart failure and reduced ejection fraction","volume":"21","author":"Wessler","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0059","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jchf.2020.08.008","article-title":"N-terminal pro-B-type natriuretic peptide and clinical outcomes: vericiguat heart failure with reduced ejection fraction study","volume":"8","author":"Ezekowitz","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.2763","article-title":"Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial","volume":"25","author":"McMurray","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0061","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0062","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11897-018-0381-0","article-title":"The future of biomarker-guided therapy for heart failure after the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) study","volume":"15","author":"Ibrahim","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0063","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: A randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0064","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jacc.2019.06.055","article-title":"Natriuretic peptide response and outcomes in chronic heart failure with reduced ejection fraction","volume":"74","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008837","article-title":"Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide: Insights from the DAPA-HF trial","volume":"14","author":"Butt","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0066","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5603\/CJ.a2015.0012","article-title":"Effects of ivabradine therapy on heart failure biomarkers","volume":"22","author":"Ordu","year":"2015","journal-title":"Cardiol J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0067","unstructured":"NATRECOR\u00ae (nesiritide) FDA label.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020920s023lbl.pdf (Accessed January 11, 2022)."},{"key":"10.1016\/j.cardfail.2023.02.009_bib0068","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0069","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ahj.2008.07.031","article-title":"Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)","volume":"157","author":"Hernandez","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0071","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0072","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ahj.2013.08.001","article-title":"Learning from recent trials and shaping the future of acute heart failure trials","volume":"166","author":"Mentz","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0073","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchf.2019.12.010","article-title":"Natriuretic peptides as inclusion criteria in clinical trials: a JACC: Heart Failure position paper","volume":"8","author":"Ibrahim","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0074","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004783","article-title":"Relationship between enrolling country income level and patient profile, protocol completion, and trial end points","volume":"11","author":"Greene","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/ejhf.934","article-title":"RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research","volume":"19","author":"Cotter","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0076","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI112723","article-title":"Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion","volume":"78","author":"Cody","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0077","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(86)92675-9","article-title":"Haemodynamic effects of atrial peptide infusion in heart failure","volume":"2","author":"Crozier","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0078","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.CIR.76.1.115","article-title":"Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function","volume":"76","author":"Saito","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0079","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","article-title":"Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: The PROTECT multicenter randomized controlled study","volume":"72","author":"Hata","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0080","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1253\/circj.CJ-07-0760","volume":"72","author":"Nomura","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0081","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2019.01.049","article-title":"Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database","volume":"280","author":"Nagai","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0082","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ehf2.13770","article-title":"Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure","volume":"9","author":"Nogi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0083","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00380-019-01450-w","article-title":"Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure","volume":"35","author":"Kamiya","year":"2020","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0084","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","article-title":"A test in context: Neprilysin: Function, inhibition, and biomarker","volume":"68","author":"Bayes-Genis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0085","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1253\/circj.CJ-17-1424","article-title":"Angiotensin receptor neprilysin inhibitor in Japanese patients with heart failure and reduced ejection fraction - Baseline characteristics and treatment of PARALLEL-HF trial","volume":"82","author":"Tsutsui","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0086","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin\u2013neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0087","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0088","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamacardio.2021.4567","article-title":"Effect of treatment with sacubitril\/valsartan in patients with advanced heart failure and reduced ejection fraction: A randomized clinical trial","volume":"7","author":"Mann","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0089","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchf.2021.09.007","article-title":"Early B-type natriuretic peptide change in HFrEF patients treated with sacubitril\/valsartan: a pooled analysis of EVALUATE-HF and PROVE-HF","volume":"10","author":"Myhre","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jchf.2020.09.013","article-title":"Atrial natriuretic peptide and treatment with sacubitril\/valsartan in heart failure with reduced ejection fraction","volume":"9","author":"Murphy","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0091","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0092","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","article-title":"Cardiac natriuretic peptides","volume":"17","author":"Goetze","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0093","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jchf.2018.10.014","article-title":"NT-probnp goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF","volume":"7","author":"Daubert","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0094","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006946","article-title":"Reverse cardiac remodeling and outcome after initiation of sacubitril\/valsartan","volume":"13","author":"Januzzi","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jchf.2020.09.013","article-title":"Atrial natriuretic peptide and treatment with sacubitril\/valsartan in heart failure with reduced ejection fraction","volume":"9","author":"Murphy","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0096","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008410","article-title":"Association between angiotensin receptor-neprilysin inhibition, cardiovascular biomarkers, and cardiac remodeling in heart failure with reduced ejection fraction","volume":"14","author":"Murphy","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0097","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cardfail.2021.08.025","article-title":"Multiple cardiac biomarker testing among patients with acute dyspnea from the ICON-RELOADED study","volume":"28","author":"Abboud","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0098","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008410","article-title":"Association between angiotensin receptor-neprilysin inhibition, cardiovascular biomarkers, and cardiac remodeling in heart failure with reduced ejection fraction","volume":"14","author":"Murphy","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0099","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.01.001","article-title":"Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase","volume":"36","author":"Ma","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes","volume":"122","author":"Bordicchia","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0101","doi-asserted-by":"crossref","first-page":"17466","DOI":"10.1038\/s41598-021-96970-9","article-title":"Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo","volume":"11","author":"Kimura","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cardfail.2020.08.012","article-title":"Possible association between body temperature and B-type natriuretic peptide in patients with cardiovascular diseases","volume":"27","author":"Kang","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0103","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.cardfail.2005.04.012","article-title":"NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation","volume":"11","author":"Knebel","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0104","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.amjcard.2007.06.035","article-title":"Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial)","volume":"100","author":"Shah","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/jcaf.2001.23355","article-title":"A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study","volume":"7","author":"Kazanegra","year":"2001","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0106","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ehj.2004.07.038","article-title":"Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure","volume":"25","author":"Gackowski","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2020.03.027","article-title":"CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation","volume":"308","author":"Soler","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0108","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: t he international collaborative of NT-proBNP Study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0109","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jacc.2018.01.021","article-title":"N-terminal pro-B-type natriuretic peptide in the Emergency Department: The ICON-RELOADED Study","volume":"71","author":"Januzzi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0111","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ejhf.669","article-title":"Variability of biomarkers in patients with chronic heart failure and healthy controls","volume":"19","author":"Meijers","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0112","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.amjcard.2006.06.017","article-title":"Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure","volume":"98","author":"Ara\u00fajo","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.02.009_bib0113","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.amjcard.2006.02.043","article-title":"Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure","volume":"98","author":"Kimmenade","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:49:22Z","timestamp":1761029362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1071916423000647"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.02.009","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc and European Society of Cardiology. Published by Elsevier Inc and Wiley. All rights reserved.","name":"copyright","label":"Copyright"}]}}